Skip to content
About
Supporter
Expert Index
Editorial Board
Editorial Team
Editorial Policy
Contact
Sign up
Visit
Home
(current)
Diseases
Parkinson's Disease
Multiple Sclerosis and Related Disorders
Headache
Amyotrophic Lateral Sclerosis
Epilepsy
Sleep Disorders
Stroke
Neuromuscular Disorders
Movement Disorders
View all Diseases
Topics
Biology
Diagnostics
Trial Updates
Treatment
Prevention
Surgery
Imaging
Genetics
COVID-19
View all Topics
Conferences
CONy 2023
ACTRIMS 2023
ISC 2023
EHC 2022
AES 2022
WSC 2022
View all Conferences
Features
Podcasts
About
Supporter
Expert Index
Editorial Board
Editorial Team
Editorial Policy
Contact
Sign up
Fabrizio Stocchi
0:53
Effects of apomorphine sublingual film on QT interval in patients with Parkinson’s disease
Fabrizio Stocchi
• 16 Sep 2022
1:26
Targeting α-synuclein & neuroinflammation in Parkinson’s disease
Fabrizio Stocchi
• 16 Sep 2022
1:38
Assessing the efficacy of antibodies targeting α-synuclein
Fabrizio Stocchi
• 16 Oct 2022
1:33
Unmet needs across movement disorders
Fabrizio Stocchi
• 16 Sep 2022
1:33
The treatment of OFF episodes in Parkinson’s disease
Fabrizio Stocchi
• 16 Sep 2022
1:39
Advancing diagnosis in Parkinson’s disease: the search for a reliable biomarker
Fabrizio Stocchi
• 25 Jun 2022
1:34
New rehabilitation approaches in Parkinson’s disease
Fabrizio Stocchi
• 25 Jun 2022
2:27
Tackling unmet needs in the symptomatic management in PD
Fabrizio Stocchi
• 25 Jun 2022
2:31
Opicapone versus entacapone for early morning dystonia in Parkinson’s disease
Fabrizio Stocchi
• 25 Jun 2022
2:32
Latest approaches to improve the delivery of levodopa
Fabrizio Stocchi
• 25 Jun 2022
1:40
An update on biomarkers for use in Parkinson’s Disease
Fabrizio Stocchi
• 18 Mar 2022
1:47
New drugs for treatment of Parkinson’s disease
Fabrizio Stocchi
• 18 Mar 2022
1:09
Potential targets for Parkinson’s disease treatment
Fabrizio Stocchi
• 18 Mar 2022
1:47
Latest developments in symptomatic treatment of Parkinson’s disease
Fabrizio Stocchi
• 18 Mar 2022
2:12
Key clinical trials of disease modifying therapies in Parkinson’s disease
Fabrizio Stocchi
• 18 Mar 2022
